| To: Wayne Rumball who started this subject | 9/19/2003 10:04:22 AM | | From: Wayne Rumball | | | | LAGUNA HILLS, Calif., Aug 26, 2003 /PRNewswire-FirstCall via COMTEX/ -- Global
Medical Products Holdings, Inc. (OTC: GMDP) announced today that it has entered
into definitive negotiations for a 3 million dollar financing package. The
negotiations are with a Far Eastern investor and are anticipated to close
shortly.
According to Doug Brown, President of Global Medical Products Holdings, Inc.,
"this will allow the Company to move forward on all aspects of its acquisition
plan. Previously announced closure settlements using restricted stock in the
Company are being rewritten whereby the consideration for the acquisitions will
be in cash. The restricted stock that was previously issued and held in trust
pending the final closure will be returned and cancelled."
The use of proceeds will be as follows:
-- $1,500,000 to eliminate existing liens on property being purchased in
Alabama
-- $400,000 which represents first two payments to Shanghai Ecom
-- $175,000 to satisfy a December 31, 2003 note due on EZ Trac Labs
-- $150,000 as part of the antibacterial licensing agreement previously
announced
-- Balance to be used as working capital and the elimination of the
amounts owed under Current Liabilities
The net results from certain payments would result in the recapture of
approximately 18,000,000 shares of common stock that have been prior issued.
Legal Notice Regarding Forward-Looking Statements: "Forward-looking statements"
as defined in the Private Securities Litigation Reform Act of 1995 may be
included in this news release. These statements relate to future events or our
future financial performance. These statements are only predictions and may
differ materially from actual future results or events. Global Medical Products
Holdings, Inc. disclaims any intention or obligation to revise any
forward-looking statements whether as a result of new information, future
developments or otherwise. There are important risk factors that could cause
actual results to differ from those contained in forward-looking statements,
including, but not limited to risks associated with changes in general economic
and business conditions, actions of our competitors, the extent to which we are
able to develop new services and markets for our services, the time and expense
involved in such development activities, the level of demand and market
acceptance of our services and changes in our business strategies.
For further information, please contact: Doug Brown of Global Medical Products
Holdings, Inc., +1-619-222-2568.
SOURCE Global Medical Products Holdings, Inc.
CONTACT: Doug Brown of Global Medical Products Holdings, Inc.,
+1-619-222-2568 |
| | Global Medical Products Holdings, Inc. (GMDP) | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
| To: Wayne Rumball who wrote (1) | 9/19/2003 10:05:58 AM | | From: Wayne Rumball | | | | LAGUNA HILLS, Calif., Aug 11, 2003 /PRNewswire-FirstCall via COMTEX/ -- Global
Medical Products Holdings, Inc. (OTC: GMDP) announced today that the last legal
proceeding against the Company has been settled and that it has made its first
payment in the settlement of the Goulding Trust v. 37Point9 (Global Medical
Products Holdings, Inc.) legal action. The second and final payment is scheduled
for November 15th.
The Company, as previously announced, is in final negotiations on a funding
package that will provide for the acquisition of a building in the southern
United States using existing preferred stock. The building, a modern 80,000
square foot structure, is located in a regional corridor of manufacturing and
industrial facilities and will be used for EZ Trac Labs, manufacturing and
office space. Additionally, the funding will allow the Company to effect the
acquisitions of Shanghai Ecom and Global Glass Source as well as fund the
manufacturing of certain patented technologies that the Company is licensing.
Doug Brown, President of Global Medical Products Holdings, Inc., stated that the
efforts to remove the stigma of previous management is finally coming to
reality. "We have worked hard to turn this Company from a 'shell' corporation
into a viable revenue generating, operating entity. The addition of EZ Trac Labs
in January has already begun the revenue process. With the completion of the
funding and subsequent effecting of the acquisitions, the Company will have an
approximate book value of $0.10 per share. This is an enormous turn-around from
the Company's position of 18 months ago," Brown stated.
Legal Notice Regarding Forward-Looking Statements: "Forward-looking statements"
as defined in the Private Securities Litigation Reform Act of 1995 may be
included in this news release. These statements relate to future events or our
future financial performance. These statements are only predictions and may
differ materially from actual future results or events. Global Medical Products
Holdings, Inc. disclaims any intention or obligation to revise any
forward-looking statements whether as a result of new information, future
developments or otherwise. There are important risk factors that could cause
actual results to differ from those contained in forward-looking statements,
including, but not limited to risks associated with changes in general economic
and business conditions, actions of our competitors, the extent to which we are
able to develop new services and markets for our services, the time and expense
involved in such development activities, the level of demand and market
acceptance of our services and changes in our business strategies.
For further information, please contact Doug Brown of Global Medical Products
Holdings, Inc., +1-888-420-4042.
SOURCE Global Medical Products Holdings, Inc.
CONTACT: Doug Brown of Global Medical Products Holdings, Inc.,
+1-888-420-4042
(GMDP) |
| | Global Medical Products Holdings, Inc. (GMDP) | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (2) |
|
| To: Wayne Rumball who wrote (2) | 9/20/2003 9:19:02 PM | | From: Mighty_Mezz | | | | If you look back over the history of this company, you'll see it stinks on ice.
Here's a letter from their prior accounting firm to the SEC.
EX-16.1
Stonefield Josephson, Inc.
Certified Public Accountants
Business Advisors
July 30, 2003
BY FAX (202) 942-9656 AND CERTIFIED MAIL
U.S. Securities and Exchange Commission
Office of Chief Accountant
450 5th Street NW
Washington, DC 20549
Re: Global Medical Products Holdings, Inc. - Cessation of Auditor Relationship
Gentlemen:
We inform you that the auditor relationship between Global Medical Products
Holdings, Inc. and Stonefield Josephson, Inc. has ceased effective July 23,
2003.
We had been engaged to audit the financial statements of Global as of December
31, 2002 and for the year then ended, which audit was never completed. During
our attempts to perform the audit, there were disagreements between management
and our firm as to matters of accounting principles or practices, financial
statement disclosure, and auditing scope and nature, which, if not resolved to
our satisfaction, would have caused reference to these matters in our auditors'
report.
During our auditor, matters came to our attention requiring us to significantly
increase the scope of our audit and, if further investigated might materially
impact a previously issued financial statement.
A summary of these matters, as required to be reported by Regulation S-K, Item
304(a)(1)(iv)(A) follows:
GLOBAL GLASS SOURCE ACQUISITION - The company had stated that it had entered
into an agreement in August 2002, for the purchase of Global Glass Source, a
Hong Kong corporation. The consideration was the issuance of shares in December
2002 to a "designated agent". We had requested information on the acquiree, such
as legal opinion of Chinese counsel relating to the acquisition, evidence of
delivery of capital stock of the acquired corporation, and financial statements
of the acquiree. This information was necessary both for purposes of financial
statement disclosures required by SFAS No. 141, as well as evidential matter to
substantiate the acquisition. As of July 15, 2003 management had informed us
that no such information was forthcoming.
There were certain changes in the terms set forth in different versions of the
acquisition agreement. Accordingly we requested that we confirm the terms
directly with the sellers. Management stated in a letter dated July 15, 2003
"There is no need to confirm".
LITIGATION SETTLEMENT - The company had recorded settlement of litigation in the
amount of $1,855,551 in 2002, based upon a settlement agreement dated December
2001. We had questioned why the liability had not been originally accrued at
December 31, 2001, as the settlement agreement presumably characterized the
amount as a liability which met the recognition criteria of SFAS No. 5 at that
date. We discussed this matter with the predecessor auditor, who had indicated
that he believed that they had EX-16.1 evidential matter substantiating its
recording in 2002, but was not aware of the December 2001 agreement, for which
we subsequently furnished a copy to them.
<PAGE>
We asked that the company obtain a response from the predecessor auditor as to
whether, in light of this December 2001 document which they purportedly did not
have, the financial statements should be amended. Management stated in its
response to us "This does not require an answer from Weinberg".
RECORDING OF INVESTMENT TRANSACTIONS - During the audit we reviewed various
correspondence that indicated that there were investments that were made in the
prior year of which the company could not furnish evidence as to recording. When
we inquired as to the appropriate accounting for several of these investments,
management informed us (i) "Investments made by the Barren-Benz Investment
Groups were not recorded during the year 2001. A cursory review of the financial
statements audited by Weinberg & Company P.A. does not indicate any entry as to
the ..... investments", (ii) "None of these items were booked into the financial
records of Global Medical Products Holdings", and (iii) "This funding was never
booked by the company as a benefit to the Benz group during 2001 and the funds
were retained by Kallmann".
We were unable to conclude as to the appropriate accounting for these
transactions based on the information that we received from management.
Inaccurate Statements in Forms 10-QSB and 10-KSB. - We received notice of
termination on July 23, 2003. In a telephone conversation with Mr. Douglas P.
Brown, President, Director and Acting Chief Financial Officer on July 24, 2003,
we informed Mr. Brown that there were reportable disagreements which must be
disclosed in our letter to be attached to the From 8-K reporting the change in
auditors. Mr. Brown responded by saying that he did not acknowledge that there
were disagreements and that he would be reporting the change in auditors in an
upcoming Form 1-QSB.
In Item 5, Part II of the company's Form 10-QSB and in Item 8 of Form 10-KSB,
both of which were filed on July 28, 2003, the company states in part, "As of
the date of this filing the Company is not aware of any written disagreements
between the Company and Stonefield Josephson, Inc. on any matter of accounting
principles, financial statement disclosures or auditing scope and procedure,
which disagreements, if not resolved to the satisfaction of Stonefield
Josephson, Inc. would have caused that accounting firm to make reference to the
subject matter of the disagreement in connection with its report."
While this statement may be technically correct - i.e. there were no WRITTEN
disagreements - we did specifically inform Mr. Brown verbally in our July 24
telephone conversation that there were, indeed, reportable disagreements.
As required by Item 304(a)(1)(iv)(B) of Regulation S-K we report that these
items were discussed at varying times with members of the board of directors,
Messrs. Karl R. Rolls and Douglas P. Brown. We were informed that the company
does not have a separate audit committee, so all communications were directly
with the board members.
/s/ Stonefield Josephson, Inc.
Stonefield Josephson, Inc.
Santa Monica, California
sec.freeedgar.com |
| | Global Medical Products Holdings, Inc. (GMDP) | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (2) |
|
| To: Mighty_Mezz who wrote (3) | 9/22/2003 9:05:43 AM | | From: Harry_Behemoth | | | | No doubt it stank horribly, but it appears new management is turning things around. Who knows?
Doug Brown, President of Global Medical Products Holdings, Inc., stated that the efforts to remove the stigma of previous management is finally coming to reality. "We have worked hard to turn this Company from a 'shell' corporation into a viable revenue generating, operating entity. The addition of EZ Trac Labs in January has already begun the revenue process. With the completion of the funding and subsequent effecting of the acquisitions, the Company will have an approximate book value of $0.10 per share. This is an enormous turn-around from the Company's position of 18 months ago," Brown stated. |
| | Global Medical Products Holdings, Inc. (GMDP) | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
| To: Harry_Behemoth who wrote (4) | 9/22/2003 11:48:21 AM | | From: Mighty_Mezz | | | | Doug Brown isn't new.
Check out the false claims he made about the alleged Global Glass acquisition during last years big pump and dump prior to the reverse split. |
| | Global Medical Products Holdings, Inc. (GMDP) | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: Wayne Rumball who wrote (2) | 10/17/2003 10:42:50 AM | | From: bigbuk | | | | Global Medical Products H (U-GMDP) - News Release
Global Medical Products Holdings, Inc. Issues Update to Company Activities
LAGUNA HILLS, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Global Medical Products Holdings, Inc. reported today that it received a letter of interest regarding a $3.5 million financing proposal on October 3, 2003, the terms of which are still being negotiated. This letter of interest and its accompanying term sheet has an expiration of October 24, 2003, however, it may be extended after that date with the approval of all parties.
The financing is contingent on the acquisition of an 80,000 square foot building located in Piedmont, Alabama. As previously announced on July 31, 2003, this building will be used to house the Company's EZ Trac Labs unit, a manufacturing area for a patented anti-bacterial compound and other uses consistent with Company's growth plan. Presently, there is a pending lease for approximately 75 percent of the building which includes restaurant and kitchen facilities. This lease is contingent on the lessee obtaining State of Alabama approval of a gaming license to operate a Bingo Hall on the premises. The licensing application is presently being reviewed by the state authority and is scheduled for action for issuance or denial on Monday October 20th. Approval of local authorities has already been granted.
This loan will allow the Company to proceed to finalize the acquisition and licensing agreements announced late last year. Although those acquisitions, Global Glass Source Ltd. and Shaghai Ecom Trading Company and the Guangzhou Lin Bi Company and Yin Kang Medical Equipment Company licensing agreements, are technically closed, the stock consideration that was given as payment was rejected in January due to the dramatic decline in the valuation of the Company's common stock. The returned stock was placed in Trust with a third party, Niagara Enterprises, Inc., pending further negotiations related to the payment consideration. This resulted in a delay in taking actual possession until sufficient financial resources were acquired to satisfy the monetary consideration that is replacing the original common stock consideration.
Additionally the Company received on October 8, 2003 an inquiry letter from the Securities and Exchange Commission, Office of Emerging Growth Companies relating to certain postings in the Company's Forms 10-KSB and 10-QSB and certain previous press releases. The Commission is requesting that the reports be revised to include additional information and exhibits. The Company believes that this is a normal inquiry and has submitted the letter to accounting and legal staff for review and response.
The Company welcomes the inquiry and the resultant filings which have been requested. The Company feels that such an inquiry can only strengthen the Company by assuring that all postings, whether in S.E.C. filings or press releases meet the guidelines and regulations promulgated by that agency and are to the benefit of shareholders and potential investors.
For further information, please contact Doug Brown of Global Medical Products Holdings, Inc., +1-619-222-2568.
Global Medical Products Holdings, Inc.
CONTACT: Doug Brown of Global Medical Products Holdings, Inc.,
+1-619-222-2568 |
| | Global Medical Products Holdings, Inc. (GMDP) | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |
